Common Contracts

FORM OF UNDERWRITING AGREEMENT _______________ Shares Anthera Pharmaceuticals, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT

Underwriting Agreement • October 19th, 2009 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 19th, 2009
• Company
  Anthera Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Anthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate of [•] shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to [•] additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.

6,250,000 Shares Physicians Formula Holdings, Inc. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENT

Underwriting Agreement • November 8th, 2006 • Physicians Formula Holdings, Inc. • Perfumes, cosmetics & other toilet preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  November 8th, 2006
• Company
  Physicians Formula Holdings, Inc.
• Industry
  Perfumes, cosmetics & other toilet preparations
• Jurisdiction
  New York

Physicians Formula Holdings, Inc., a Delaware corporation (the “Company”), and certain stockholders of the Company (the “Selling Stockholders”) propose to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 6,250,000 shares (the “Firm Shares”) of the Company’s common stock, $.01 par value (the “Common Stock”), of which 3,125,000 shares will be sold by the Company and 3,125,000 shares will be sold by the Selling Stockholders. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto, and the respective amounts to be sold by the Selling Stockholders are set forth opposite their names in Schedule II hereto. The Company and the Selling Stockholders are sometimes referred to herein collectively as the “Sellers.” Certain Selling Stockholders also propose to sell at the Underwriters’ option an agg